Clinical Trials Browser

Phase 2 × Adenocarcinoma × avelumab × Clear all

NCT03000179 2022-04-14

Safety and Efficacy of Avelumab in Small Intestinal Adenocarcinoma

Phase 2 Terminated

8 enrolled 12 charts

Adenocarcinoma